Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Malena Mahendran"'
Autor:
Damian May, Kalé Kponee-Shovein, Jeffrey L. Neul, Alan K. Percy, Malena Mahendran, Nathaniel Downes, Grace Chen, Talissa Watson, Dominique C. Pichard, Melissa Kennedy, Patrick Lefebvre
Publikováno v:
Journal of Neurodevelopmental Disorders, Vol 16, Iss 1, Pp 1-12 (2024)
Abstract Background With the advent of the first targeted therapy for Rett Syndrome (RTT), a comprehensive assessment of the journey of RTT is needed to elucidate on present unmet needs in this population. This study characterized females with RTT in
Externí odkaz:
https://doaj.org/article/85d4f235fe314dd9b90f1126e2424377
Autor:
Julie Priest, Guillaume Germain, François Laliberté, Mei Sheng Duh, Malena Mahendran, Iman Fakih, Alan Oglesby
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2117-2133 (2023)
Abstract Introduction Dolutegravir/lamivudine (DTG/3TC) is a 2-drug regimen for HIV-1 treatment with long-term efficacy and good tolerability comparable to 3- or 4-drug regimens. This study evaluated DTG/3TC cost versus other standard single-tablet r
Externí odkaz:
https://doaj.org/article/38a79db97baf4f47b325076395e0f2f1
Autor:
Damian M May, Jeffrey Neul, Jesus Eric Pina-Garza, Kale Kponee-Shovein, Ambika Satija, Malena Mahendran, Nathaniel Downes, Kristy Sheng, Neema Lema, Andra Boca, Patrick Lefebvre, Victor Abler, James M Youakim, Wendy Y Cheng
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2023)
Aim: Patients with Rett syndrome (RTT) experience gastrointestinal (GI) manifestations. This study aimed to describe the prevalence of GI manifestations and the associated medical costs in patients with RTT in the USA. Patients & Methods: The study
Externí odkaz:
https://doaj.org/article/5cc5079a790f43a39c7bbd21326fc217
Autor:
Damian May, Kalé Kponee-Shovein, Malena Mahendran, Nathaniel Downes, Kristy Sheng, Patrick Lefebvre, Wendy Y. Cheng
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background Rett syndrome (RTT) is a neurodevelopmental disorder that almost exclusively affects females and is associated with high clinical burden. However, literature characterizing the real-world journey of patients with RTT is limited. T
Externí odkaz:
https://doaj.org/article/13fa26b4a6eb4179a0b9db6a6b690bbd
Autor:
Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Michel Delforge, Nirali Kotowsky, Jacopo Bitetti, Natalie Boytsov, Leena Camadoo-O’byrne, Lindsey Powers Happ, Mujib Rohman, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee
Publikováno v:
HemaSphere, Vol 7, p e20009f4 (2023)
Externí odkaz:
https://doaj.org/article/a182f50d2d1d418bb9ef6217311aeba2
Autor:
David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Malena Mahendran, Beth Hahn
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Adherence to chronic obstructive pulmonary disease (COPD) maintenance medication is important for managing symptoms and exacerbation risk, and is associated with reduced mortality, hospitalizations, and costs. This study compared
Externí odkaz:
https://doaj.org/article/099bfe989c864240a05bbe222630d846
Autor:
Keith C. Ferdinand, Kay Sadik, Richard Browne, Urvi Desai, Patrick Lefebvre, Dominique Lejeune, Malena Mahendran, François Laliberté, Lisa Matay, David G. Armstrong
Publikováno v:
Advances in Therapy. 40:1850-1866
Autor:
Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Nirali Kotowsky, Jacopo Bitetti, Christine Mackay, Natalie Boytsov, Leena Camadoo-O'Byrne, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee
Publikováno v:
Blood. 140:10124-10126
Autor:
Neal D. Shore, Louise Yu, Dominique Lejeune, S. Ghate, François Laliberté, Jeri Kim, Lingfeng Yang, Mei Sheng Duh, Malena Mahendran, Raluca Ionescu-Ittu
Publikováno v:
Clinical Genitourinary Cancer. 19:480-490
Background Real-world evidence suggest that next generation hormonal agents (NHAs) abiraterone and enzalutamide were preferred as first-line (1L) therapies for metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) pre-2020
Autor:
Dominique Lejeune, François Laliberté, Louise Yu, Lingfeng Yang, Mei Sheng Duh, Malena Mahendran, Neal D. Shore, Raluca Ionescu-Ittu, S. Ghate, J. Burgents
Publikováno v:
Future Oncology. 17:2907-2921
Aim: To assess the patterns of genetic testing for homologous recombination repair mutations in patients with metastatic castration-resistant prostate cancer (mCRPC) pre-PARP inhibitors approval. Patients & methods: mCRPC patients were selected in an